Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com
Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Wednesday. Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price objective on shares of Puma Biotechnology in a report on Friday, February 28th. […]
More Stories
Kevin Warsh Wants an Overhaul of the Fed—Here’s What That Could Look Like
By Andrew Moran Former Federal Reserve Governor Kevin Warsh has been nominated by President Donald Trump to be the new...
US Forces Shoot Down Iranian Drone Over Arabian Sea
By Ryan Morgan A U.S. fighter jet shot down an Iranian drone as it approached a U.S. aircraft carrier in...
Ex-Husband of Jill Biden Arrested and Charged With Murder
By Zachary Stieber The ex-husband of former First Lady Jill Biden has been arrested in Delaware for allegedly murdering his...
Musk’s SpaceX Acquires xAI to ‘Accelerate Humanity’s Future’
By Troy Myers Two of entrepreneur Elon Musk’s most pioneering companies, SpaceX and xAI, merged Monday with a combined goal...
Groundhog Day 2026: Punxsutawney Phil Spots His Shadow, and You Know What That Means
By Elma Aksalic Punxsutawney Phil, the Pennsylvania groundhog and central figure to the Feb. 2 tradition, delivered a disappointing weather...
Trump Launches $12 Billion ‘Project Vault’ Critical Minerals Stockpile
By Catherine Yang President Donald Trump announced on Feb. 2 a new strategic private sector critical minerals stockpile. “Project Vault”...